The interpretation of these results was that the disruption of the PD-1/PD-L1 axis during the T cell priming phase abrogated functionality of CD8+ CTLs, required to keep EBV infection and tumor development under control (25). The gene discussed is CD8A; the disease is Epstein-Barr virus infection.